These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of opioid peptides in cardiovascular regulation. New developments in the treatment of shock? Lamberts SW Neth J Med; 1984; 27(10):417-20. PubMed ID: 6096743 [No Abstract] [Full Text] [Related]
26. Naloxone: ineffective in improving cardiac performance after hypoperfusion in swine. Heydorn WH; Moores WY; Bellamy RF; O'Benar JD Circ Shock; 1985; 17(1):35-43. PubMed ID: 2932263 [TBL] [Abstract][Full Text] [Related]
27. Naloxone for haemorrhagic fever shock? Xing R; Yi X; Guang-Min L; Yuan-Wen W Trop Doct; 1990 Apr; 20(2):72-3. PubMed ID: 1973008 [No Abstract] [Full Text] [Related]
29. [Therapeutic effect of naloxone and its mechanisms in circulation shock]. He F; Zheng MQ Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):137-43. PubMed ID: 2555915 [No Abstract] [Full Text] [Related]
31. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock. Gurll NJ; Vargish T; Reynolds DG; Lechner RB Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256 [TBL] [Abstract][Full Text] [Related]
32. [Naloxone and endogenous opiates in shock]. Nielsen JV; Lundgren LG Lakartidningen; 1984 Oct; 81(41):3717-8. PubMed ID: 6094928 [No Abstract] [Full Text] [Related]
33. The effects of vasoactive mediator antagonists on endotoxic shock in dogs. I. Toth PD; Hamburger SA; Judy WV Circ Shock; 1984; 12(4):277-86. PubMed ID: 6722995 [TBL] [Abstract][Full Text] [Related]
34. Effect of naloxone on shock in a patient with fulminant hepatic failure. De Groot GH; Schalm SW; Dirksen R; Valk KC; Boks AL Neth J Med; 1983; 26(3):77-9. PubMed ID: 6843740 [No Abstract] [Full Text] [Related]
35. Effect of temperature on naloxone treatment in canine hemorrhagic shock. Horton JW; Tuggle DW; Kiser RS Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039 [TBL] [Abstract][Full Text] [Related]
36. [Naloxone hydrochloride in the therapy of endotoxic shock following meningococcal disease. Initial results]. Martinón JM; Franco A; García JL; Fuster M; Bao A; Martinón F; Peña J An Esp Pediatr; 1982 Dec; 17(6):457-60. PubMed ID: 7183216 [No Abstract] [Full Text] [Related]
37. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. Faden AI; Holaday JW J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345 [TBL] [Abstract][Full Text] [Related]
38. Naloxone and focal epilepsy: a study with depth electrodes. Montplaisir J; Saint-Hilaire JM; Walsh JT; Laverdière M; Bouvier G Neurology; 1981 Mar; 31(3):350-2. PubMed ID: 6782507 [TBL] [Abstract][Full Text] [Related]
39. Naloxone does not prevent death after rapid hemorrhage in swine. Traverso LW; Bellamy RF; Hollenbach SJ; O'Benar JD Surg Gynecol Obstet; 1985 Sep; 161(3):229-39. PubMed ID: 4035538 [TBL] [Abstract][Full Text] [Related]
40. [The clinical administration of the opioid antagonist naloxone in dogs]. Erhardt W; Stephan M; Geissdörfer K; Schindele M; Ascherl R; Stemberger A Tierarztl Prax; 1987; 15(2):213-8. PubMed ID: 3039690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]